The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Duration: November 1, 2007
to
May 31, 2017
General Issues: Medicare/Medicaid , Health Issues
Spending: about $1,510,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Centers For Medicare and Medicaid Services (CMS),, Treasury - Dept of, Federal Trade Commission (FTC), Y
Y
CMS, FDA
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Colin Roskey Health Policy Adv'r & Counsel, Sen. Finance Cmte
Dan Elling Staff Director, Ways and Means Health Subcmte
Prof. Staff, Ways and Means Health Subcmte
Health Policy Aide, Rep. Nancy Johnson
Legislative Assistant, Rep. Jim Ramstad
Carolyn Smith Health Pol. Adv'r & Counsel, Sen. Fin. Comm.
Bob Siggins Chief of Staff for Rep. Earl Pomeroy
Regina Sherick Staff Assistant, Senate Finance Committee
Earl Pomeroy U.S. Congressman for North Dakota
Danielle White Intern, Senate HELP Committee; Intern, HHS Office of General Counsel (CMS Division); Intern, Staff Assistant and Executive Assistant, Rep. Nancy Johnson.
Thomas A. Scully n/a
M. LYNN SYKES n/a
JENNIFER L. BUTLER n/a
ERIN L. DARLING n/a
David Hebert n/a
Marc Scheineson n/a
Jennifer Bell n/a
Thomas Scully n/a
Marilyn Yager n/a
Rudy Missmar n/a
Tiffani Williams n/a
Jennifer Butler n/a
Tim Trysla n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2017
ALSTON & BIRD LLP terminated an engagement in which they represented FRESENIUS MEDICAL CARE on July 20, 2017.
Original Filing: 300893560.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, ALSTON & BIRD LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on April 20, 2017.
Original Filing: 300873753.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, ALSTON & BIRD LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Jan. 23, 2017.
Original Filing: 300855205.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, ALSTON & BIRD LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Oct. 20, 2016.
Original Filing: 300835750.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, ALSTON & BIRD LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on July 20, 2016.
Original Filing: 300817690.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, ALSTON & BIRD LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on April 20, 2016.
Original Filing: 300798406.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Jan. 19, 2016.
Original Filing: 300775230.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Oct. 20, 2015.
Original Filing: 300764686.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on July 19, 2015.
Original Filing: 300740107.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ESRD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458), Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on April 19, 2015.
Original Filing: 300721071.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies;Final Rule [CMS-1526-F]; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ESRD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458), Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Jan. 16, 2015.
Original Filing: 300699193.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93);The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148);The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240);Medicare Program; End-Stage Renal Disease Prospective Payment
System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies;Final Rule [CMS-1526-F]; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ESRD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014).
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Oct. 17, 2014.
Original Filing: 300681102.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152);The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F];Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace
Development), 4 February 2014; contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on July 10, 2014.
Original Filing: 300654973.xml
Lobbying Issues
Protecting Access to Medicare Act of 2014" (Public Law No. 113.93); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014.
Also contacted the Center for Consumer Information & Insurance Oversight (CCIIO).
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on April 21, 2014.
Original Filing: 300648693.xml
Lobbying Issues
Protecting Access to Medicare Act of 2014 (Public Law No. 113.93); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F];CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014.
Also contacted the Center for Consumer Information & Insurance Oversight (CCIIO).
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Jan. 21, 2014.
Original Filing: 300626071.xml
Lobbying Issues
Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Bad Debt Reductions for All Medicare Providers; Proposed Rule [CMS CMS-1352-P]; The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240).
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Oct. 21, 2013.
Original Filing: 300607249.xml
Lobbying Issues
Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Bad Debt Reductions for All Medicare Providers; Proposed Rule [CMS CMS-1352-P]; The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240).
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on July 22, 2013.
Original Filing: 300586206.xml
Lobbying Issues
CY 2013 End-Stage Renal Disease Prospective Payment System Final Rule (CMS-1352-F); the Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240);Medicare Program: Comprehensive End-Stage Renal Disease Care Model Announcement (CMS-5506-N).
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on April 22, 2013.
Original Filing: 300562736.xml
Lobbying Issues
CY 2013 End-Stage Renal Disease Prospective Payment System Final Rule (CMS-1352-F); the Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240);Medicare Program: Comprehensive End-Stage Renal Disease Care Model Announcement (CMS-5506-N).
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Jan. 22, 2013.
Original Filing: 300541756.xml
Lobbying Issues
CY 2013 End-Stage Renal Disease Prospective Payment System Final Rule (CMS-1352-F); the Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240)
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Oct. 22, 2012.
Original Filing: 300520653.xml
Lobbying Issues
CMS-6037-P: Medicare Program; Reporting and Returning of Overpayments: Proposed Rule; The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152).
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on July 20, 2012.
Original Filing: 300497508.xml
Lobbying Issues
CMS-6037-P: Medicare Program; Reporting and Returning of Overpayments: Proposed Rule; The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152).
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on April 20, 2012.
Original Filing: 300473880.xml
Lobbying Issues
Essential Health Benefits Bulletin, released by the Consumer Information and Insurance Oversight (CCIIO) on December 16, 2011; Medicare, Medicaid, Childrens Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests (Proposed Rule) (CMS5060P); The Patient Protection and Affordable Care Act (P.L. 111-148);
The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Jan. 20, 2012.
Original Filing: 300452690.xml
Lobbying Issues
CMS-9070-P: Medicare and Medicaid Program; Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction: Proposed Rule; Agency Information Collection: Independent Renal Dialysis Facility Cost Report; Document Identifier CMS-265-11 (Notice); Health Insurance Premium Tax Credit Regulation (REG 131491-10); Patient Protection and Affordable Care Act; Establishment of Exchanges and Qualified Health Plans; Proposed rule [CMS-9989-P].
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2011
In Q3, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Oct. 20, 2011.
Original Filing: 300428384.xml
Lobbying Issues
The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program; Changes to the End-Stage Renal Disease Prospective Payment System for CY 2012, End-Stage Renal Disease Quality Incentive Program for PY 2013 and PY 2014; Proposed Rule (CMS-1577-P); Patient Protection and Affordable Care Act; Establishment of Exchanges and Qualified Health Plans, and Standards Related to Reinsurance, Risk Corridors and Risk Adjustment; Extension of Comment Period [CMS-9989-N2]; Patient Protection and Affordable Care Act; Exchange Functions in the Individual Market: Eligibility Determinations; Exchange Standards for Employers: Proposed Rule [CMS-9974-P]; Health Insurance Premium Tax Credits: Proposed Rule (REG-131491-10).
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2011
In Q2, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on July 20, 2011.
Original Filing: 300405725.xml
Lobbying Issues
The Patient Protection and Affordability Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Programs; Changes to the ESRD Prospective Payment System Transition Budget Neutrality Adjustment (CMS-1435-IFC).
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2011
In Q1, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on April 20, 2011.
Original Filing: 300379931.xml
Lobbying Issues
The Patient Protection and Affordability Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Office of the National Coordinator, Comments on Stage 2 and Stage 3 Meaningful Use Measures; Medicare Programs; Changes to the ESRD Prospective Payment System Transition Budget Neutrality Adjustment (CMS-1435-IFC).
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Jan. 20, 2011.
Original Filing: 300354691.xml
Lobbying Issues
The Patient Protection and Affordability Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program; End-Stage Renal Disease Prospective Payment System; Proposed Rule (CMS-1418-P); Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011; Proposed Rule (CMS-1503-P).
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Oct. 20, 2010.
Original Filing: 300329009.xml
Lobbying Issues
The Patient Protection and Affordability Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program; End-Stage Renal Disease Prospective Payment System; Proposed Rule (CMS-1418-P); Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011; Proposed Rule (CMS-1503-P); HIT incentives, "Meaningful Use."
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on July 20, 2010.
Original Filing: 300303153.xml
Lobbying Issues
PL 111-148 Patient Protection and Affordable Care Act; PL 111-152 Health Care and Education Reconciliation Act of 2010; Medicare Program; End-Stage Renal Disease Prospective Payment System; Proposed Rule (CMS-1418-P); Dep't of Veterans Affairs "Payment for Inpatient and Outpaitent Health Care Professional Services at Non-Departmental Facilities and Other Medical Charges Associated with Non-VA Outpatient Care" (38 CFR part 17, RIN 2900-AN37;Internal Revenue Service, Proposed Regulation Relating to Withholding on Payments by Governmental Entities under Code Section 3402(t) CC:PA:LPD:PR (REG-158747-06)
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on April 20, 2010.
Original Filing: 300274746.xml
Lobbying Issues
Senate Health Reform Bill - Patient Protection and Affordable Care Act (H.R. 3590); House Health Reform Bill -
Affordable Health Care for America Act (H.R. 3962); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program; End-Stage Renal Disease Prospective Payment System; Proposed Rule (CMS-1418-P)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Jan. 20, 2010.
Original Filing: 300247927.xml
Lobbying Issues
Medicare Program: Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010; Final Rule (CMS-1413-FC)
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Oct. 20, 2009.
Original Filing: 300222190.xml
Lobbying Issues
America's Affordable Health Choices Act of 2009 (HR 3200); Affordable Health Choices Act (S. 1679); House Tri-Committee and Senate Finance Health Reform Proposals; Medicare Program: End-Stage Renal Disease Prospective Payment System: Proposed Rule ("CMS-1418-P"); Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for
CY 2010; Proposed Rule ("CMS-1413-P")
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on July 20, 2009.
Original Filing: 300187529.xml
Lobbying Issues
S. 1/H.R. 1, American Recovery and Reinvestment Act
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; and Revisions to the Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; Proposed Rule: (CMS-1403-P, 07/07/2008) Re: Section II.N.2: Physician Self Referral and Anti-Markup Issues; Exception for Incentive Payment and Shared Savings Programs"
Proposed Regulation Relating to Withholding on Payments by Government Entities under Code Section 3402(t)
Health Care Reform
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on April 20, 2009.
Original Filing: 300164640.xml
Lobbying Issues
S. 1/H.R. 1, American Recovery and Reinvestment Act
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; and Revisions to the Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; Proposed Rule: (CMS-1403-P, 07/07/2008) Re: Section II.N.2: Physician Self Referral and Anti-Markup Issues; Exception for Incentive Payment and Shared Savings Programs"
Proposed Regulation Relating to Withholding on Payments by Government Entities under Code Section 3402(t)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
In Q4, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Jan. 21, 2009.
Original Filing: 300133619.xml
Lobbying Issues
S. 691/H.R. 1193, The Kidney Care Quality and Education Act of 2007.
H.R. 6331: "Medicare Improvements for Patients and Providers Act of 2008"
S. 1, Economic Recovery/StimulusMedicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; and Revisions to the Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; Proposed Rule: (CMS-1403-P, 07/07/2008) Re: Section II.H. "Provisions Related to Payment for Renal Dialysis Services Furnished by End-Stage Renal Disease (ESRD) Facilities;" Re: Section II.N.2: "Physician Self Referral and Anti-Markup Issues; Exception for Incentive Payment and Shared Savings Programs;"
Transactions contemplated in Federal Trade Commission Decisions and Orders.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on Oct. 20, 2008.
Original Filing: 300106451.xml
Lobbying Issues
S. 691/H.R. 1193, The Kidney Care Quality and Education Act of 2007.
H.R. 6331: "Medicare Improvements for Patients and Providers Act of 2008" ; Sections 152, 153, 164.Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; and Revisions to the Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; Proposed Rule" (CMS-1403-P, 07/07/2008) Re: Section II.H. Provisions Related to Payment for Renal Dialysis Services Furnished by End-Stage Renal Disease (ESRD) Facilities;" Re: Section II.N.2: "Physician Self Referral and Anti-Markup Issues: Exception for Incentive Payment and Shared Savings Programs;"
Transactions contemplated in Federal Trade Commission Decisions and Orders.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on July 21, 2008.
Original Filing: 300082819.xml
Lobbying Issues
S. 691/H.R. 1193, The Kidney Care Quality and Education Act of 2007.
S. 3101: "Medicare Improvements for Patients and Providers Act of 2008" ; Sections 153, 154, 164.
H.R. 6331: "Medicare Improvements for Patients and Providers Act of 2008" ; Sections 152, 153, 164.
S. 3118: "Preserving Access to Medicare Act of 2008"; Sections 151, 152, 163.Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; and Revisions to the Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; Proposed Rule" (CMS-1403-P, 07/07/2008) Re: Section II.H. Provisions Related to Payment for Renal Dialysis Services Furnished by End-Stage Renal Disease (ESRD) Facilities."
S. 3236: Medicare and Medicaid Extension Act of 2008; Section 112.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $40,000. The report was filed on April 17, 2008.
Original Filing: 300042053.xml
Lobbying Issues
S. 691/H.R. 1193, The Kidney Care Quality and Education Act of 2007; S. 2449/P.L. No. 110-173, The Medicare, Medicaid and S-CHIP Extension Act of 2007, provisions related to dialysis, MSP and phosphate binders.
Agencies Lobbied
U.S. House of Representatives
0th Quarter, 2007
In MM, ALSTON & BIRD, LLP lobbied for FRESENIUS MEDICAL CARE , earning $80,000. The report was filed on Aug. 6, 2007.
Original Filing: 200046837.xml
Lobbying Issues
Medicare Outpatient bundling, Medicare Part D nutrition issues
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...